Actuate Therapeutics Inc

NASDAQ:ACTU

Biotechnology

Healthcare
$2.09 +2.96%

+$0.06 today

Market cap
$50.01M
Beta
0.53
P/E (TTM)
-2.3
EPS (TTM)
-$0.92
52W Low $1.58High $9.22

Volume 0.03M

Average 0.16M

Price history

Actuate Therapeutics Inc SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-64.27%

Period high

$7.63

Period low

$1.72

Latest

$2.09

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
4May 22, 2026May 22, 2026
4May 22, 2026May 22, 2026
8-KMay 22, 2026May 22, 2026
4May 22, 2026May 22, 2026
4May 22, 2026May 22, 2026
4May 22, 2026May 22, 2026
4May 22, 2026May 22, 2026
4May 22, 2026May 22, 2026
S-8May 14, 2026May 14, 2026
10-QMay 14, 2026May 14, 2026
8-KMay 11, 2026May 11, 2026
3May 6, 2026May 6, 2026
DEFA14AMay 6, 2026May 6, 2026
8-KMay 6, 2026May 6, 2026
SC 13G/AApr 22, 2026Apr 22, 2026

Competitors

Who does Actuate Therapeutics Inc compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about ACTU's filings, answered from its disclosures.

What is the latest ACTU filing?

The latest filing shown is 4 dated May 22, 2026.

How many recent filings does ACTU have?

Intrinsic Alpha currently shows 20 recent filings for ACTU.